IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.847
EU - Europa 1.336
AS - Asia 750
SA - Sud America 2
AF - Africa 1
Totale 3.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.822
IE - Irlanda 377
UA - Ucraina 368
SG - Singapore 246
HK - Hong Kong 178
VN - Vietnam 157
IT - Italia 118
FI - Finlandia 106
SE - Svezia 94
DE - Germania 91
CN - Cina 87
RU - Federazione Russa 64
TR - Turchia 38
GB - Regno Unito 34
KR - Corea 29
BE - Belgio 26
CA - Canada 20
FR - Francia 12
CH - Svizzera 10
NL - Olanda 8
LB - Libano 7
UZ - Uzbekistan 7
AT - Austria 5
GR - Grecia 5
MX - Messico 5
PL - Polonia 5
CZ - Repubblica Ceca 4
RO - Romania 4
BR - Brasile 2
ES - Italia 2
LT - Lituania 2
GH - Ghana 1
IN - India 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.936
Salva come PNG Salva come JPEG
Città #
Chandler 383
Dublin 377
Jacksonville 214
Singapore 208
San Mateo 181
Hong Kong 178
Dong Ket 157
Boardman 98
Ann Arbor 93
Santa Clara 78
Medford 77
Princeton 77
Wilmington 55
Andover 48
Izmir 38
Beijing 37
Ashburn 31
Helsinki 30
Perugia 29
Des Moines 24
Brussels 23
Saint Petersburg 21
Ottawa 18
Altamura 17
Genoa 17
Munich 16
Norwalk 15
Woodbridge 15
Dongjak-gu 14
Seoul 13
Lawrence 10
Redwood City 10
Los Angeles 9
Houston 8
Shanghai 7
Frankfurt am Main 6
Redmond 6
Falls Church 5
Auburn Hills 4
Den Haag 4
Corciano 3
Dearborn 3
Heusden 3
London 3
Milan 3
Moscow 3
Rome 3
Sona 3
Terni 3
Amsterdam 2
Cuernavaca 2
Dallas 2
Faenza 2
Fortaleza 2
Frankfurt Am Main 2
Madrid 2
New York 2
Philadelphia 2
Pistoia 2
Sacheon-si 2
Timisoara 2
Toronto 2
Turin 2
Andra 1
Augusta 1
Bethesda 1
Bratislava 1
Bucharest 1
Como 1
Costa Mesa 1
Florence 1
Hangzhou 1
Hanover 1
Lenzburg 1
Messina 1
Mexico 1
Miami 1
Muenster 1
Nanchang 1
Newark 1
Olomouc 1
Romola 1
San Jose 1
San Paolo di Civitate 1
Sandston 1
Seattle 1
Solon 1
St Petersburg 1
Stockholm 1
Tempio Pausania 1
Vienna 1
Warsaw 1
Totale 2.735
Salva come PNG Salva come JPEG
Nome #
"Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age" 4th National Congress of the Italian Society of Virology (SIV) 92
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 91
" MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004)" 88
An influenza A/H3N2 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home 87
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti anziani residenti in casa di riposo” 36° Congresso Nazionale della Società Italiana di Microbiologia 83
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 83
I benefici della vaccinazione influenzale Analisi e prospettive nella popolazione non anziana a rischio 81
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine” 7th National Congress of the Italian Society of Virology 80
Annually repeated influenza vaccination and humoral response in elderly volunteers. 77
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 72
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 71
An influenza B outbreak in elderly vaccinated people in the winter season 2007/2008” The Third European Influenza Conference 69
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 67
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 67
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 66
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 63
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 62
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 62
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 62
Proceedings of the X National Biotechnology Congress. 61
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 61
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 61
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 61
Influenza vaccination in patients on long-term anticoagulant therapy 61
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 60
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 60
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008” 8th National Congress of the Italian Society of Virology 57
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 57
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 56
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 56
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 56
[Natural resistance and induced resistance to ATPC + tumor in mice]. 56
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 55
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 55
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 53
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 52
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 50
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 50
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 50
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 49
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 49
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 49
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 49
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 48
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 48
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 48
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 47
Radioresistant Inhibition of Tumors (RIT): Biological and Pharmacological Studies 47
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 47
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 46
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 46
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 46
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 46
Sorveglianza delle paralisi flaccide acute nella regione Umbria 43
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 42
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. 41
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 41
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 41
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 40
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 40
[Selective inhibition of the response to the allograft of a virus in mice] 40
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 38
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 38
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 37
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 37
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 36
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 36
Influenza A virus specific T cell immunity in humans during ageing 36
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 36
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 35
Influenza vaccination in patients on long-term anticoagulant therapy 34
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 33
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 31
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 30
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 27
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 27
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 20
Totale 4.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020210 0 0 0 0 0 3 57 17 60 35 9 29
2020/2021751 14 57 10 61 207 23 74 3 65 14 61 162
2021/2022581 11 109 4 14 26 6 6 211 5 23 76 90
2022/20231.113 89 109 20 93 88 119 0 63 484 3 35 10
2023/2024483 32 45 30 9 3 1 125 28 71 4 86 49
2024/2025438 15 114 31 59 181 38 0 0 0 0 0 0
Totale 4.075